Vaccines: past, present and future
Top Cited Papers
- 5 April 2005
- journal article
- review article
- Published by Springer Nature in Nature Medicine
- Vol. 11 (S4) , S5-S11
- https://doi.org/10.1038/nm1209
Abstract
The vaccines developed over the first two hundred years since Jenner's lifetime have accomplished striking reductions of infection and disease wherever applied. Pasteur's early approaches to vaccine development, attenuation and inactivation, are even now the two poles of vaccine technology. Today, purification of microbial elements, genetic engineering and improved knowledge of immune protection allow direct creation of attenuated mutants, expression of vaccine proteins in live vectors, purification and even synthesis of microbial antigens, and induction of a variety of immune responses through manipulation of DNA, RNA, proteins and polysaccharides. Both noninfectious and infectious diseases are now within the realm of vaccinology. The profusion of new vaccines enables new populations to be targeted for vaccination, and requires the development of routes of administration additional to injection. With all this come new problems in the production, regulation and distribution of vaccines.Keywords
This publication has 80 references indexed in Scilit:
- From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenzaNature Reviews Microbiology, 2004
- Modified Vaccinia Ankara: Potential as an Alternative Smallpox VaccineClinical Infectious Diseases, 2004
- Vaccines for the prevention of diseases caused by potential bioweaponsClinical Immunology, 2004
- Immune Response of Healthy Women to 2 Different Group B Streptococcal Type V Capsular Polysaccharide–Protein Conjugate VaccinesThe Journal of Infectious Diseases, 2004
- Discontinuation of Antiretroviral Therapy Commenced Early during the Course of Human Immunodeficiency Virus Type 1 Infection, with or without Adjunctive VaccinationThe Journal of Infectious Diseases, 2002
- Successful Boosting of a DNA Measles Immunization with an Oral Plant-Derived Measles Virus VaccineJournal of Virology, 2002
- Clinical Reactogenicity of Intradermal Bacille Calmette‐Guérin VaccinationClinical Infectious Diseases, 1999
- DiscussionVaccine, 1997
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- GENETIC STUDIES OF INFLUENZA VIRUSESThe Journal of Experimental Medicine, 1960